Literature DB >> 18674783

Prepulse inhibition of startle in adults with ADHD.

David Feifel1, Arpi Minassian, William Perry.   

Abstract

Prepulse inhibition of startle (PPI) is a measure of sensorimotor gating, a pre-conscious regulator of attention. PPI is impaired in adults with schizophrenia and several other neuropsychiatric disorders associated with attentional abnormalities. The core feature of ADHD involves deficits in attention and, like schizophrenia, ADHD is associated with dysregulation of cortical-striatal circuits and dopamine transmission. Therefore, PPI may be disrupted in ADHD. While ADHD persists into adulthood in approximately half the children with ADHD, there has not been any published report of PPI in ADHD adults. In this study, PPI was measured in a sample of ADHD adults and compared to a sample of healthy comparison (HC) subjects. Twenty unmedicated adults with ADHD (11 inattentive subtype, 9 combined subtype) and 17 HC subjects were administered an eyeblink startle PPI paradigm. The PPI of ADHD adults was not significantly different from that of HC subjects in any of the PPI conditions. There was no significant effect of ADHD subtype nor of gender. The lack of PPI deficits in ADHD adults has important implications and suggests that, despite the presence of PPI dysregulation in a large number of disparate neuropsychiatric disorders, it is not a general feature of all neuropsychiatric disorders with attention abnormalities. Furthermore, the attentional deficiency in ADHD may have a neurobiological substrate somewhat distinct from schizophrenia and other neuropsychiatric disorders that are associated with PPI deficits. This distinction may be related to a relative sparing of pre-conscious attentional functions in ADHD compared to other disorders with PPI impairment.

Entities:  

Mesh:

Year:  2008        PMID: 18674783      PMCID: PMC2669714          DOI: 10.1016/j.jpsychires.2008.06.004

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  33 in total

1.  Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.

Authors:  Larry J Seidman; Eve M Valera; Nikos Makris; Michael C Monuteaux; Denise L Boriel; Kalika Kelkar; David N Kennedy; Verne S Caviness; George Bush; Meg Aleardi; Stephen V Faraone; Joseph Biederman
Journal:  Biol Psychiatry       Date:  2006-07-28       Impact factor: 13.382

2.  Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis.

Authors:  E M Ornitz; A T Russell; G L Hanna; P Gabikian; J G Gehricke; D Song; D Guthrie
Journal:  Biol Psychiatry       Date:  1999-06-01       Impact factor: 13.382

3.  The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients.

Authors:  Arpi Minassian; David Feifel; William Perry
Journal:  Schizophr Res       Date:  2006-09-26       Impact factor: 4.939

Review 4.  Attention-deficit/hyperactivity disorder: a selective overview.

Authors:  Joseph Biederman
Journal:  Biol Psychiatry       Date:  2004-12-18       Impact factor: 13.382

5.  Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients.

Authors:  David L Braff; Gregory A Light; Neal R Swerdlow
Journal:  Biol Psychiatry       Date:  2006-12-08       Impact factor: 13.382

6.  A comparison of prepulse inhibition in pre- and postmenopausal women and age-matched men.

Authors:  Veena Kumari; Ingrid Aasen; Andrew Papadopoulos; Fanta Bojang; Lucia Poon; Rozmin Halari; Anthony J Cleare
Journal:  Neuropsychopharmacology       Date:  2008-01-23       Impact factor: 7.853

7.  Effects of olanzapine, risperidone and haloperidol on prepulse inhibition in schizophrenia patients: a double-blind, randomized controlled trial.

Authors:  Jonathan K Wynn; Michael F Green; Joyce Sprock; Gregory A Light; Clifford Widmark; Christopher Reist; Stephen Erhart; Stephen R Marder; Jim Mintz; David L Braff
Journal:  Schizophr Res       Date:  2007-07-26       Impact factor: 4.939

Review 8.  Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology.

Authors:  Thomas J Spencer; Joseph Biederman; Eric Mick
Journal:  J Pediatr Psychol       Date:  2007-06-07

9.  Sensorimotor gating deficits in adults with autism.

Authors:  William Perry; Arpi Minassian; Brian Lopez; Leeza Maron; Alan Lincoln
Journal:  Biol Psychiatry       Date:  2006-02-07       Impact factor: 13.382

Review 10.  Targeting the dopamine system in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Jud A Staller; Stephen V Faraone
Journal:  Expert Rev Neurother       Date:  2007-04       Impact factor: 4.618

View more
  16 in total

1.  Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder.

Authors:  Rebecca L Ashare; Larry W Hawk; Keri Shiels; Jessica D Rhodes; William E Pelham; James G Waxmonsky
Journal:  Psychophysiology       Date:  2010-03-10       Impact factor: 4.016

2.  Role of purinergic P2X4 receptors in regulating striatal dopamine homeostasis and dependent behaviors.

Authors:  Sheraz Khoja; Vivek Shah; Damaris Garcia; Liana Asatryan; Michael W Jakowec; Daryl L Davies
Journal:  J Neurochem       Date:  2016-08-15       Impact factor: 5.372

Review 3.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

4.  Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates.

Authors:  Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

5.  Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.

Authors:  Antonio Ortega-Álvaro; Francisco Navarrete; Auxiliadora Aracil-Fernández; Daniela Navarro; Pere Berbel; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2015-04-21       Impact factor: 7.853

6.  Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy.

Authors:  J G Howland; B N Cazakoff; Y Zhang
Journal:  Neuroscience       Date:  2011-11-11       Impact factor: 3.590

Review 7.  Epigenetics and biomarkers in the staging of neuropsychiatric disorders.

Authors:  Trevor Archer; Richard J Beninger; Tomas Palomo; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2010-03-17       Impact factor: 3.911

Review 8.  Sensorimotor gating of the startle reflex: what we said 25 years ago, what has happened since then, and what comes next.

Authors:  Neal R Swerdlow; David L Braff; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2016-08-18       Impact factor: 4.153

9.  The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding.

Authors:  Jared W Young; Susan B Powell; Christine N Scott; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2011-03-31       Impact factor: 3.332

10.  Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Authors:  Brook L Henry; Mark A Geyer; Mahalah R Buell; William Perry; Jared W Young; Arpi Minassian
Journal:  Behav Pharmacol       Date:  2014-02       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.